Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Bluejay Diagnostics, Inc. has entered into agreements for a private placement to raise up to $23.6 million, including $8.5 million upfront and approximately $15.1 million via exercise of warrants. The funds are intended to extend the company's cash runway into 2027, supporting FDA approval processes and commercialization of their near-patient sepsi…